Founded by Saint Pio in 1956, Casa Sollievo della Sofferenza combines compassionate care and scientific excellence. Now a leading Italian Research Hospital (IRCCS), it contributes specialized expertise in pregnancy-related thrombosis to the ThrombUS+ European Project.
Meet the Partner
12 posts
Papageorgiou General Hospital is one of the largest and most prestigious hospitals in Greece, and a major partner involved in the Clinical Studies of the ThrombUS+ project. ThrombUS+ is tasked with creating a wearable device for the autonomous detection of deep vein thrombosis.
The Lithuanian University of Health Sciences (LSMU), one of Europe's largest life sciences universities with over 8,000 students, contributes as the clinical partner to the ThrombUS+ Horizon Europe project developing innovative wearable technology for deep vein thrombosis detection and monitoring.
Tampere University is responsible for studying the use of electrical impedance plethysmography technology for detecting deep vein thrombosis in the ThrombUS+ project.
ComfTech is an innovative manufacturer of wearable monitoring systems based on smart garments. As part of the ThrombUS+ project, ComfTech contributes its expertise in smart textiles and wearable systems by designing sensorized garments for the early detection of deep vein thrombosis
medis GmbH: Expert developers of medical impedance measurement and Light-Reflection-Rheography technology for DVT detection in the ThrombUS+ project. Discover how their non-invasive diagnostic innovations are revolutionizing blood clot monitoring and prevention for cardiovascular health.
SciGen Technologies is a software development company responsible for bringing eposters to the global market. SciGen is responsible for the communication and dissemination of the ThrombUS+ project, tasked with creating a wearable diagnostic device for the early detection of deep vein thrombosis.
Telemed is a pioneer in the field of medical imaging and ultrasound technology. Read about their involvement in the ThrombUS+ Horizon Europe project to develop a novel wearable diagnostic device for early detection of Deep Vein Thrombosis.
Fraunhofer IPMS is a pivotal member of the ThrombUS+ project. Read more about their involvement in developing a novel wearable diagnostic device for early detection of Deep Vein Thrombosis.
Learn more about Vermon, designer and manufacturer of ultrasound transducers and partner in the ThrombUS+ Horizon EU project, working to create a wearable device to diagnose deep vein thrombosis (DVT).